Teaching Diabetes Management Using Two Different Methods (Teaching)
30 aprile 2026 aggiornato da: Amasya University
The Effects of Teaching Diabetes Management to Nursing Students Using Two Different Methods on Knowledge Level, Critical Thinking, and Self-Efficacy
It is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes.
Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Panoramica dello studio
Stato
Completato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Introduction and Aim: To provide effective diabetes education for nursing students, it is essential to evaluate teaching methods and include comprehensive teaching components for optimal educational outcomes. Accordingly, this study will evaluate the effect of teaching diabetes management to nursing students using two different methods.
Methods: The research will be conducted using a quasi-experimental research design with a pre-test/post-test control group. The sample will consist of students enrolled in the Internal Medicine Nursing course at a university nursing department. Data will be collected in two time periods: after theoretical information on diabetes and treatment/care practices is provided, and after jigsaw and case-based learning applications are completed. Students will be divided into three groups: jigsaw learning group, case-based learning group, and control group. Data will be collected using a Personal Information Form, Diabetes Knowledge Test, Critical Thinking Tendency Scale, and Self-Efficacy Scale.
Tipo di studio
Interventistico
Iscrizione (Effettivo)
88
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Luoghi di studio
-
-
-
Amasya, Turchia (Türkiye)
- AmasyaU
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- Students enrolled in the Internal Medicine Nursing course during the 2023-2024 academic year,
- Students who attended the "diabetes management" theoretical course in Internal Medicine Nursing,
- Students who agreed to participate in the study.
Exclusion Criteria:
- Students who did not participate in the theoretical and jigsaw/case-based learning application phases of the study,
- Students who did not give their consent to participate in the study.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Altro
- Assegnazione: Non randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: jigsaw
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
Students in the jigsaw group will be divided into 5 groups of six.
Then, the topic content will be divided into five outlines (diabetes classification/symptoms and signs, diabetes treatment (nutrition and exercise), diabetes treatment (insulin and oral antidiabetics), acute and chronic complications of diabetes, patient education in diabetes), and each member of each jigsaw group will be assigned to a specific outline.
Students will be asked to study all the material by looking more closely at the given topic.
Then, all students assigned to the same outline in the 5 jigsaw groups will be gathered in a group called the "expert group."
In this expert group, each student will be asked to share and discuss the information they have gained regarding the specific outline with the other students.
|
|
Sperimentale: case based
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
The researcher will provide the students with 5 examples, and five case studies will be conducted with the students in the case-based learning group (cases will include information such as the patient's detailed history, medical diagnosis, a brief summary of the disease, and the medications the patient is using).
The case studies used will contain the basic details of diabetes.
Necessary background information will be provided, and discussion questions will be determined.
|
|
Nessun intervento: control
Control group: Students in the control group will not be given the simulation exercise; they will only fill out data collection forms during two designated time periods.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Diabetes Knowledge Test
Lasso di tempo: 4 week
|
The knowledge test will consist of 20 questions on the physiology, signs, and treatment of septic shock.
The questions in the knowledge test will be sent to 5 experts for review, and content validity will be established.
|
4 week
|
|
Critical Thinking Tendency Scale
Lasso di tempo: 4 week
|
The "Critical Thinking Tendency Scale" was developed in 2012 by Karalı and Battal to measure critical thinking tendencies.
The CTTS is a five-point Likert-type scale consisting of 21 items.
The scale has two sub-dimensions: "Skills Dimension" and "Values Dimension".
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91 (Karalı and Battal, 2012).
The highest possible score on the "Skills" subscale of the "Critical Thinking Tendency Scale" is 60, and the lowest is 12.
The highest possible score on the "Values" subscale is 45, and the lowest is 9.
The Cronbach's alpha internal consistency reliability coefficient of the scale was found to be 0.91.
|
4 week
|
|
Self-Efficacy Scale
Lasso di tempo: 4 week
|
The scale is unidimensional and consists of 10 positive items, therefore it does not contain reverse-coded items.
Each item is given a score between 1 and 4, in equal intervals.
A higher score indicates higher self-efficacy.
The Cronbach's alpha internal consistency reliability coefficient of the scale adapted into Turkish and whose validity and reliability analyses were performed by Yurtçiçek Eren and Başgöl was found to be 0.81.
|
4 week
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
15 ottobre 2025
Completamento primario (Effettivo)
15 dicembre 2025
Completamento dello studio (Effettivo)
16 gennaio 2026
Date di iscrizione allo studio
Primo inviato
24 aprile 2026
Primo inviato che soddisfa i criteri di controllo qualità
30 aprile 2026
Primo Inserito (Effettivo)
4 maggio 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
4 maggio 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
30 aprile 2026
Ultimo verificato
1 aprile 2026
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- AU-689
- NU689 (Altro identificatore: Amasya U)
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .